Kevin Robert Lind
Director · Avalo Therapeutics, Inc.
Individual
- 2024
- Oct 2, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Robert Lind files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Morningside Venture Investments Ltd - $5.00M in APMD purchases and sales in the last 12 months
- Christopher Ryan Sullivan - $3.72M in AVTX purchases and sales in the last 12 months
- Mittie Doyle - $2.98M in AVTX purchases and sales in the last 12 months
- Paul Varki - $1.51M in AVTX purchases and sales in the last 12 months
- Paul J. Sekhri - $200K in APMD purchases and sales in the last 12 months
- Jonathan Goldman - $163K in AVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Robert Lind?
Kevin Robert Lind is a corporate insider, tracked as Director of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin Robert Lind submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
